Maximizing the Clinical Utility of Next Generation Sequencing

In this informative webinar, Eric Vail, MD, director of molecular pathology, Cedars-Sinai Medical Center, will discuss how testing programs have positively transformed patient care. Vail will also explain how organizations can maximize the clinical utility of patient reports by leveraging electronic medical record data and standardizing interpretation language. During the webinar, Vail will examine various reports, discuss NTRK and other challenging variants, and share best practices he has adopted within his own laboratory.

Thanks to genetic testing, more opportunities than ever exist to improve outcomes for cancer patients. A patient’s tumor can now be sequenced, genomic variants detected and interpreted, and data placed into a genomic report to share with physicians, all in a relatively short period of time. Yet the genomic information itself can present challenges. Dr. Rakesh Nagarajan, founder and the Executive Chairman of the Board at PierianDx, provides a prologue, introduces the PierianDx platform, and then hands the discussion to Dr. Vail.